8-(4-sulfophenyl)theophylline has been researched along with Cirrhosis in 1 studies
8-(4-sulfophenyl)theophylline: adenosine antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wakeno, M | 1 |
| Minamino, T | 1 |
| Seguchi, O | 1 |
| Okazaki, H | 1 |
| Tsukamoto, O | 1 |
| Okada, K | 1 |
| Hirata, A | 1 |
| Fujita, M | 1 |
| Asanuma, H | 1 |
| Kim, J | 1 |
| Komamura, K | 1 |
| Takashima, S | 1 |
| Mochizuki, N | 1 |
| Kitakaze, M | 1 |
1 other study available for 8-(4-sulfophenyl)theophylline and Cirrhosis
| Article | Year |
|---|---|
Long-term stimulation of adenosine A2b receptors begun after myocardial infarction prevents cardiac remodeling in rats.
Topics: 2-Chloroadenosine; Acetamides; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; An | 2006 |